Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 18/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1189271 | 0.83 | CHRM3 (0.47) | CHRM3ADRB2HTR1AHTR7GAA | |
| SCHEMBL5650688 | 0.75 | ADRB2 (0.78) | CHRM3ADRB2 | |
| Hydrochloric Acid SCHEMBL1257200 | 0.75 | ADRB2 (0.77) | CHRM3ADRB2 | |
| SCHEMBL1257265 | 0.74 | ADRB2 (0.80) | CHRM3ADRB2 | |
| SCHEMBL1191356 | 0.73 | CHRM3 (0.59) | CHRM3ADRB2GAA | |
| SCHEMBL13717362 | 0.69 | SIGMAR1 (0.70) | GAA | |
| SCHEMBL1257363 | 0.69 | CHRM3 (0.80) | CHRM3ADRB2 | |
| SCHEMBL1257366 | 0.69 | CHRM3 (0.80) | CHRM3ADRB2 | |
| SCHEMBL1257368 | 0.69 | CHRM3 (0.80) | CHRM3ADRB2 | |
| SCHEMBL1191417 | 0.69 | KDM4E (0.46) | CHRM3ADRB2HTR1AHTR7GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592685-A1 | BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | Theravance Inc (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004074276-A1 | BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | THERAVANCE INC. (US) | 2004-09-02 | — | — | WO | disclosed |